Avalon Ventures is an early stage venture capital fund focused on information technology and life sciences.
Business Model:
Revenue: $6.7M
Employees: 2-10
Address: 1134 Kline Street
City: La Jolla
State: CA
Zip: 92037
Country: US
Avalon’s long-standing and successful focus has been on seed and early stage companies, including many it formed in the life science and information technology sectors. We believe this is the most challenging and rewarding period of company creation – we are former entrepreneurs driven by passionate people pursuing disruptive ideas in ever changing market environments.
Contact Phone:
+18583482180
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
12/2006 | Chumby | Series A | 5M |
3/2015 | Nanigans | Series B | 24M |
2/2017 | Piper Networks | Venture Round | 5.8M |
4/2017 | NanoNets | Seed Round | 1.4M |
12/2008 | Cloudant | Series A | 1M |
2/1999 | TomoTherapy | Series A | 3M |
2/2015 | Overlap.cc | Pre Seed Round | - |
9/2010 | Backupify | Series A | 4.5M |
1/2014 | Chartio | Venture Round | 2.2M |
9/2021 | Joy | Series A | 0 |
5/2018 | BotChain | Venture Round | 5M |
11/2008 | Zacharon Pharmaceuticals | Series A | 3.5M |
4/2013 | Nanigans | Series A | 5.8M |
1/2012 | MOGL | Series B | 12M |
3/2007 | Amira Pharmaceuticals | Series B | 25M |
2/2011 | Kaltura | Series C | 20M |
7/2016 | AristaMD | Series A | 11M |
1/2013 | LoopIt | Seed Round | - |
4/2018 | Synthorx | Series C | 63M |
6/2008 | Kaltura | Series B | 21M |
4/2003 | Ansata Therapeutics | Series B | 2.5M |
6/2015 | Ankasa Regenerative Therapeutics | Series A | 8.5M |
4/2020 | Figg | Funding Round | - |
11/2007 | BioVex | Series E | 35M |
10/2003 | BioVex | Series C | 28.4M |
7/2014 | ScoreStream | Convertible Note | 800k |
10/2014 | StackIQ | Series B | 6M |
5/2009 | E-Band Communications | Series C | - |
2/1992 | Metra Biosystems | Venture Round | - |
9/2014 | Sidecar Technologies | Series C | 15M |
7/2006 | AnaptysBio | Series A | 2M |
9/2011 | RethinkDB | Series A | 0 |
10/2012 | Proximal Data | Series A | 3M |
12/2015 | AlphaSheets | Seed Round | 5.5M |
6/2006 | Kalon Semiconductor | Series A | 10.9M |
2/2014 | Empyr | Series B | 10.5M |
5/2013 | Happy Cloud | Series A | 4.3M |
12/2010 | Cloudant | Series A | 1M |
2/2012 | Memrise | Seed Round | 0 |
11/2014 | Redbooth | Series B | 11M |
7/2012 | Backupify | Series C | 9M |
6/2021 | Primer | Series C | 0 |
1/2015 | Primer | Seed Round | - |
2/2013 | Simulmedia | Series C | 5M |
9/2011 | Backupify | Series B | 5M |
6/2012 | Cardeas Pharma | Series A | 8.5M |
3/2017 | Smyte | Series A | 4M |
1/2014 | Quippi | Venture Round | 2M |
12/2012 | Cheezburger | Venture Round | 5M |
11/2012 | Pingup | Series A | 4M |
6/2015 | Calporta Therapeutics | Series A | 10M |
1/2011 | Cheezburger | Venture Round | 30M |
12/2000 | Ambit Biosciences | Series B | 18.8M |
7/2007 | Awarepoint | Series B | 2M |
5/2007 | Kaltura | Series A | 2.1M |
2/2000 | ChoiceSeat technology | Venture Round | 22.4M |
11/2006 | Amira Pharmaceuticals | Series A | 4M |
10/2011 | Chartio | Series A | 3.1M |
3/2018 | Averon | Series A | 11.7M |
10/2017 | Averon | Series A | 8.3M |
3/2020 | AristaMD | Series B | 0 |
1/2010 | Pictela | Venture Round | 1.5M |
10/2018 | Seva Inc. | Seed Round | 2.4M |
11/2011 | Standing Cloud | Venture Round | 3M |
7/2011 | Shelby.tv | Seed Round | 1.5M |
9/2014 | Kinvey | Series B | 10.9M |
6/2012 | Awarepoint | Venture Round | 14M |
2/2016 | Orion Labs | Series A | 9M |
12/2008 | Awarepoint | Series D | 13.3M |
5/2005 | Ambit Biosciences | Series C | 31M |
8/2011 | Nanigans | Series A | 3M |
5/2014 | BookBub | Series A | 3.8M |
6/2010 | Otonomy | Series A | 10M |
4/2010 | Cloudkick | Series A | 2M |
3/2014 | Indix | Series A | 8.5M |
1/2015 | StackRox | Seed Round | - |
3/2006 | Awarepoint | Series A | 4M |
11/2008 | Selectable Media | Venture Round | 2.6M |
11/2010 | Standing Cloud | Series B | 3M |
10/2007 | Awarepoint | Series C | 3M |
10/2012 | Selectable Media | Series A | 2M |
3/2011 | Tapad | Angel Round | 0 |
9/2014 | Avelas Biosciences | Series B | 7.4M |
1/2014 | Avelas Biosciences | Series B | 6.8M |
1/2009 | Pictela | Series A | 1.3M |
12/2013 | Simulmedia | Series D | 25M |
10/2004 | Vocera Communications | Venture Round | 6M |
12/2011 | Cloudant | Venture Round | 2.1M |
11/2017 | ScoreStream | Series A | 0 |
7/2012 | Shelby.tv | Series A | 2.2M |
11/2006 | Vocera Communications | Series F | 7M |
2/2005 | Cambrios Technologies | Series B | 12M |
4/2007 | Cambrios Technologies | Series C | 18.5M |
11/2009 | Cambrios Technologies | Series D | 14.5M |
1/2015 | Primer | Venture Round | - |
4/2013 | Indix | Series A | 6M |
7/2015 | AeroFS | Series B | 10M |
9/2013 | Otonomy | Series C | 45.9M |
10/2014 | Empyr | Venture Round | 11M |
8/2015 | Skycatch | Series B | 0 |
8/2015 | MOGL | Venture Round | 7.9M |
3/2021 | Janux Therapeutics | Series A | 0 |
5/2015 | Tapad | Series B | 0 |
8/2016 | Avelas Biosciences | Series C | 0 |
6/2015 | Pronoun | Series B | 3.5M |
10/2014 | MOGL | Venture Round | 11M |
4/2015 | Cardeas Pharma | Series B | 37.5M |
10/2011 | TwinStrata | Series B | 8M |
9/2008 | Afraxis | Series A | 1.5M |
7/2012 | Byliner | Series A | - |
4/2013 | Proximal Data | Series B | 2M |
12/2015 | Enlibrium | Series A | 15M |
6/2010 | Chartio | Seed Round | 0 |
6/2020 | Pando | Series A | 0 |
12/2017 | Pando | Seed Round | 3.1M |
8/2021 | Jnana Therapeutics | Series B | 50M |
9/2014 | Thyritope Biosciences | Series A | 10M |
10/2013 | Redbooth | Series A | 5M |
5/2014 | Skycatch | Venture Round | 13.2M |
6/2017 | Talla | Series A | 8.3M |
2/2011 | RQx Pharmaceuticals | Series A | 7M |
11/2012 | Kaltura | Series D | 25M |
1/2011 | Aratana Therapeutics | Series A | 0 |
8/2005 | Intercasting | Series A | 5.5M |
3/2013 | Tapad | Series B | 6.5M |
5/2007 | Intercasting | Series B | 12M |
7/2013 | Conjur | Seed Round | - |
10/2009 | JustSpotted | Seed Round | 750k |
4/2014 | Synthorx | Series A | 3.1M |
11/2013 | Sitari Pharmaceuticals | Series A | 10M |
9/2014 | Silarus Therapeutics | Series A | 10M |
2/2011 | MOGL | Series A | 2.4M |
6/2015 | Cadherx Therapeutics | Series A | 10M |
12/2012 | Avelas Biosciences | Series A | 7.7M |
6/2018 | Memrise | Series B | 15.5M |
3/2008 | Chumby | Series B | 12.5M |
7/2012 | Kinvey | Series A | 5M |
5/2015 | BookBub | Series B | 7M |
4/2012 | Simulmedia | Series C | 6M |
6/2015 | Indix | Series B | 15M |
7/2008 | Zynga | Series B | 25M |
11/2007 | AnaptysBio | Series B | 0 |
11/2022 | Jnana Therapeutics | Series C | 0 |
2/2007 | Inogen | Series D | 22M |
6/2019 | Simulmedia | Series E | 29M |
2/2014 | Sidecar Technologies | Series B | 10M |
8/2015 | Empyr | Venture Round | 7.9M |
9/2018 | Joy | Series A | 0 |
6/2014 | Tapad | Series B | 0 |
3/2020 | Orion Labs | Series B | 0 |
1/2008 | Zynga | Series A | 0 |
2/2008 | Zynga | Series A | 5M |
3/2009 | Simulmedia | Series A | 4M |
5/2011 | Simulmedia | Series C | 9.3M |
4/2010 | Simulmedia | Series B | 8M |
10/2022 | Enlaza Therapeutics | Seed Round | 61M |
7/2016 | Synthorx | Series B | 10M |
8/2005 | Amira Pharmaceuticals | Series A | 3M |
12/2011 | Aratana Therapeutics | Series B | 15M |
4/2007 | Syndax Pharmaceuticals | Series A | 40M |
3/2010 | Syndax Pharmaceuticals | Series A | 9M |
2/2011 | Empyr | Series A | 2.4M |
1/2012 | Empyr | Series B | 12M |
7/2019 | Node | Venture Round | 0 |
4/2021 | Janux Therapeutics | Series B | 0 |
2/2014 | MOGL | Series B | 10.5M |
12/2017 | Jnana Therapeutics | Series A | 50M |
4/2014 | Otonomy | Series D | 49M |
4/2015 | ScoreStream | Seed Round | 3M |
9/2011 | Techstars | Venture Round | 24M |
12/2014 | Conjur | Venture Round | 2.6M |
5/2013 | Cloudant | Series B | 12M |
6/2016 | Node | Seed Round | 7.5M |
9/2009 | Cloudkick | Seed Round | 750k |
4/2010 | RethinkDB | Seed Round | 1.2M |
9/2016 | Fortis Therapeutics | Series A | 18M |
3/2021 | Fortis Therapeutics | Series A | 0 |
6/2007 | Ortiva Wireless | Series B | 15M |
3/2010 | Ad Summos | Venture Round | 3M |
9/2021 | Joy | Series A | 0 |
8/2021 | Jnana Therapeutics | Series B | 0 |
6/2021 | Primer | Series C | 0 |
4/2021 | Janux Therapeutics | Series B | 0 |
3/2021 | Fortis Therapeutics | Series A | 0 |
3/2021 | Janux Therapeutics | Series A | 0 |
6/2020 | Pando | Series A | 0 |
4/2020 | Figg | Funding Round | - |
3/2020 | AristaMD | Series B | 0 |
3/2020 | Orion Labs | Series B | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|